Company Filing History:
Years Active: 2018
Title: Innovations by Manas Kumar Basu: A Focus on CCR9 Modulators
Introduction
Manas Kumar Basu is a notable inventor based in Ghaziabad, India. With a significant contribution to pharmaceutical science, he has developed innovative compounds that hold promise in treating immune disorders.
Latest Patents
Manas Kumar Basu holds a patent for "Compounds useful as CCR9 modulators." This invention pertains to compounds that can modulate the function of the CCR9 receptor, acting as partial agonists, antagonists, or inverse agonists. The implications of this technology are profound, as it may provide new avenues for treating and preventing diseases connected to CCR9 activation, particularly inflammatory bowel diseases (IBD) and other immune disorders.
Career Highlights
Currently, Manas is employed at Norgine B.V., where he applies his expertise in the development of innovative pharmaceutical solutions. His work not only contributes to his personal career achievements but also advances the overall mission of his company in developing effective therapies.
Collaborations
Throughout his career, Manas Kumar Basu has collaborated with esteemed colleagues, including Rajagopal Bakthavatchalam and Ajit Kumar Behera. These partnerships have been vital in driving research and enhancing the development of novel therapeutic compounds.
Conclusion
Manas Kumar Basu's contributions to the field of pharmaceutical innovation, particularly through his patent on CCR9 modulators, underscore his role as a pioneer in addressing significant health challenges. His work at Norgine B.V. and collaboration with talented colleagues highlights a commitment to advancing medical science for the benefit of patients worldwide.